Caris Life Sciences Stock Analysis

CAI Stock  USD 26.41  0.57  2.11%   
Caris Life Sciences holds a debt-to-equity ratio of 2.41. As of now, Caris Life's Debt Ratio is increasing as compared to previous years. With a high degree of financial leverage come high-interest payments, which usually reduce Caris Life's Earnings Per Share (EPS).

Asset vs Debt

Equity vs Debt

Caris Life's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Caris Life's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Caris Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Caris Life's stakeholders.
For most companies, including Caris Life, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Caris Life Sciences, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Caris Life's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Book Value
(18.45)
Operating Margin
(0.48)
Profit Margin
(0.60)
The Caris Life's current Non Current Liabilities Total is estimated to increase to about 3.2 B, while Liabilities And Stockholders Equity is projected to decrease to under 375.5 M.
Caris Life Sciences is fairly valued with Real Value of 27.13 and Hype Value of 26.44. The main objective of Caris Life stock analysis is to determine its intrinsic value, which is an estimate of what Caris Life Sciences is worth, separate from its market price. There are two main types of Caris Life's stock analysis: fundamental analysis and technical analysis.
The Caris Life stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Caris Life's ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Caris Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Caris Stock Analysis Notes

About 48.0% of the company shares are held by company insiders. The company has Price/Earnings To Growth (PEG) ratio of 0.9. Caris Life Sciences recorded a loss per share of 1.25. The entity last dividend was issued on the 9th of September 2021. CAI International, Inc. operates as a transportation finance company in the United States, Switzerland, France, Korea, Singapore, rest of Asia, rest of Europe, and internationally. CAI International, Inc. was incorporated in 1989 and is headquartered in San Francisco, California. Cai International operates under Rental Leasing Services classification in the United States and is traded on New York Stock Exchange. It employs 99 people. For more info on Caris Life Sciences please contact Timothy Page at 866 771 8946 or go to https://www.carislifesciences.com.

Caris Life Sciences Investment Alerts

Caris Life Sciences generated a negative expected return over the last 90 days
Caris Life Sciences has high historical volatility and very poor performance
Caris Life Sciences has 424.26 M in debt with debt to equity (D/E) ratio of 2.41, meaning that the company heavily relies on borrowing funds for operations. Caris Life Sciences has a current ratio of 0.44, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Caris to invest in growth at high rates of return.
The entity reported the last year's revenue of 412.26 M. Reported Net Loss for the year was (281.89 M) with profit before taxes, overhead, and interest of 211.38 M.
Caris Life Sciences has about 38.81 M in cash with (245.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.26.
Roughly 48.0% of Caris Life shares are held by company insiders
Latest headline from news.google.com: Why Caris Life Sciences stock is down today as biotech slips - ts2.tech

Caris Largest EPS Surprises

Earnings surprises can significantly impact Caris Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-11-05
2025-09-30-0.140.080.22157 
2025-08-12
2025-06-30-0.22-1.11-0.89404 
View All Earnings Estimates

Caris Life Environmental, Social, and Governance (ESG) Scores

Caris Life's ESG score is a quantitative measure that evaluates Caris Life's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Caris Life's operations that may have significant financial implications and affect Caris Life's stock price as well as guide investors towards more socially responsible investments.

Caris Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 7.94 B.

Caris Profitablity

The company has Net Profit Margin of (0.6) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.48) %, which entails that for every $100 of revenue, it lost $0.48.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.00)(0.95)
Return On Capital Employed(1.66)(1.58)
Return On Assets(0.94)(0.90)
Return On Equity 0.11  0.13 

Management Efficiency

The Caris Life's current Return On Equity is estimated to increase to 0.13, while Return On Tangible Assets are forecasted to increase to (0.95). As of now, Caris Life's Debt To Assets are increasing as compared to previous years. The Caris Life's current Fixed Asset Turnover is estimated to increase to 8.78, while Total Assets are projected to decrease to under 375.5 M. Caris Life's management efficiency ratios could be used to measure how well Caris Life manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share(8.83)(8.39)
Tangible Book Value Per Share(8.90)(8.45)
Enterprise Value Over EBITDA(47.09)(44.73)
Price Book Value Ratio(3.28)(3.12)
Enterprise Value Multiple(47.09)(44.73)
Price Fair Value(3.28)(3.12)
Evaluating the management effectiveness of Caris Life allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Caris Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Operating Margin
(0.48)
Profit Margin
(0.60)

Technical Drivers

As of the 5th of January, Caris Life shows the Mean Deviation of 2.35, risk adjusted performance of (0.02), and Standard Deviation of 3.37. Caris Life Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Caris Life Sciences Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Simple Moving Average indicator is calculated by adding the closing price of Caris Life for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Caris Life Sciences short-term fluctuations and highlight longer-term trends or cycles.

Caris Life Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Caris Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Caris Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Caris Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Caris Life Outstanding Bonds

Caris Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Caris Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Caris bonds can be classified according to their maturity, which is the date when Caris Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Caris Life Predictive Daily Indicators

Caris Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Caris Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Caris Life Corporate Filings

F4
12th of December 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
10th of November 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
5th of November 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
30th of October 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
12th of September 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
14th of August 2025
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
13A
13th of August 2025
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
8K
12th of August 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

Caris Life Forecast Models

Caris Life's time-series forecasting models are one of many Caris Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Caris Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Caris Life Bond Ratings

Caris Life Sciences financial ratings play a critical role in determining how much Caris Life have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Caris Life's borrowing costs.
Piotroski F Score
5
HealthyView
Beneish M Score
(3.08)
Unlikely ManipulatorView

Caris Life Sciences Debt to Cash Allocation

As Caris Life Sciences follows its natural business cycle, the capital allocation decisions will not magically go away. Caris Life's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Caris Life Sciences has 424.26 M in debt with debt to equity (D/E) ratio of 2.41, meaning that the company heavily relies on borrowing funds for operations. Caris Life Sciences has a current ratio of 0.44, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Caris to invest in growth at high rates of return.

Caris Life Total Assets Over Time

Caris Life Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Caris Life uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Caris Life Debt Ratio

    
  117.0   
It feels like most of the Caris Life's assets are financed through debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Caris Life's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Caris Life, which in turn will lower the firm's financial flexibility.

Caris Life Corporate Bonds Issued

Most Caris bonds can be classified according to their maturity, which is the date when Caris Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Caris Short Long Term Debt Total

Short Long Term Debt Total

871.92 Million

As of now, Caris Life's Short and Long Term Debt Total is decreasing as compared to previous years.

About Caris Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Caris Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Caris shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Caris Life. By using and applying Caris Stock analysis, traders can create a robust methodology for identifying Caris entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.79)(0.75)
Operating Profit Margin(0.72)(0.68)
Net Loss(0.79)(0.75)
Gross Profit Margin 0.50  0.72 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Caris Life to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Comparator Now

   

Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account
All  Next Launch Module

Complementary Tools for Caris Stock analysis

When running Caris Life's price analysis, check to measure Caris Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caris Life is operating at the current time. Most of Caris Life's value examination focuses on studying past and present price action to predict the probability of Caris Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caris Life's price. Additionally, you may evaluate how the addition of Caris Life to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.